M. Franco G. Salvoza

Array ( [id] => 9517793 [patent_doc_number] => 20140154285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'FUSION PROTEINS FOR USE AS IMMUNOGENIC ENHANCERS FOR INDUCING ANTIGEN-SPECIFIC T CELL RESPONSES' [patent_app_type] => utility [patent_app_number] => 14/095760 [patent_app_country] => US [patent_app_date] => 2013-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8744 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13051925 [patent_doc_number] => 10047347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-14 [patent_title] => Oncolytic adenoviruses with increased proportion of the 156R splicing isoform of the E1B protein [patent_app_type] => utility [patent_app_number] => 14/648661 [patent_app_country] => US [patent_app_date] => 2013-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15194 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11388745 [patent_doc_number] => 09549976 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-01-24 [patent_title] => 'Affinity selection of Nipah and Hendra virus-related vaccine candidates from a complex random peptide library displayed on bacteriophage virus-like particles' [patent_app_type] => utility [patent_app_number] => 14/081629 [patent_app_country] => US [patent_app_date] => 2013-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8857 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14081629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13182555 [patent_doc_number] => 10106781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-23 [patent_title] => Recombinant adenoviruses and use thereof [patent_app_type] => utility [patent_app_number] => 14/443299 [patent_app_country] => US [patent_app_date] => 2013-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 17587 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10643623 [patent_doc_number] => 09360485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Eukaryotic expression system and use thereof' [patent_app_type] => utility [patent_app_number] => 14/070850 [patent_app_country] => US [patent_app_date] => 2013-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6115 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14070850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10474862 [patent_doc_number] => 20150359879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'RECOMBINANT PARTICLE BASED VACCINES AGAINST HUMAN CYTOMEGALOVIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 14/436943 [patent_app_country] => US [patent_app_date] => 2013-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 18271 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9756806 [patent_doc_number] => 20140287507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'Incorporation of Plant Virus Particles and Polymers as 2D and 3D Scaffolds to Manipulate Cellular Behaviors' [patent_app_type] => utility [patent_app_number] => 14/062059 [patent_app_country] => US [patent_app_date] => 2013-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 24194 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14062059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10365864 [patent_doc_number] => 20150250869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'VIRUS-CONTAINING FORMULATION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/433142 [patent_app_country] => US [patent_app_date] => 2013-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16544 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11033192 [patent_doc_number] => 20160230148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'PRODUCTION OF VIRUS OCCLUSION BODIES THAT OCCLUDE VIRIONS COMPRISING GENOMES OF DIFFERENT SPECIES OF BACULOVIRUSES THAT CAN BE USED TO COMBAT INSECT PESTS' [patent_app_type] => utility [patent_app_number] => 15/024207 [patent_app_country] => US [patent_app_date] => 2013-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13923 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10365832 [patent_doc_number] => 20150250837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'ONCOLYTIC VIRUS ENCODING PD-1 BINDING AGENTS AND USES OF THE SAME' [patent_app_type] => utility [patent_app_number] => 14/429673 [patent_app_country] => US [patent_app_date] => 2013-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19072 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10693766 [patent_doc_number] => 20160039913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'THE USE OF ANTIBODIES IN TREATING HIV INFECTION AND SUPPRESSING HIV TRANSMISSION' [patent_app_type] => utility [patent_app_number] => 14/427117 [patent_app_country] => US [patent_app_date] => 2013-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21604 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12409155 [patent_doc_number] => 09969985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Modified human rotaviruses and uses therefor [patent_app_type] => utility [patent_app_number] => 14/423660 [patent_app_country] => US [patent_app_date] => 2013-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 77 [patent_no_of_words] => 12159 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338817 [patent_doc_number] => 20140065599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'NOVEL POLYMAVIRUS ASSOCIATED WITH DIARRHEA IN CHILDREN' [patent_app_type] => utility [patent_app_number] => 13/973544 [patent_app_country] => US [patent_app_date] => 2013-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32654 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13973544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10298838 [patent_doc_number] => 20150183836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'Compositions and Methods for Conformationally Stabilizing Primate Immunodeficiency Virus Envelope Glycoprotein Trimers' [patent_app_type] => utility [patent_app_number] => 14/418544 [patent_app_country] => US [patent_app_date] => 2013-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 44012 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11844600 [patent_doc_number] => 09732144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-15 [patent_title] => 'Infectious bursal disease (IBDV) vaccine compositions' [patent_app_type] => utility [patent_app_number] => 13/982714 [patent_app_country] => US [patent_app_date] => 2013-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25505 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10574165 [patent_doc_number] => 09296792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Ordered flagellin array as an immunostimulant' [patent_app_type] => utility [patent_app_number] => 13/901392 [patent_app_country] => US [patent_app_date] => 2013-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11036 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10938835 [patent_doc_number] => 20140341856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'METHOD OF CONTROLLING TOMATO PLANT VIRUSES' [patent_app_type] => utility [patent_app_number] => 13/898426 [patent_app_country] => US [patent_app_date] => 2013-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4809 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13898426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9175220 [patent_doc_number] => 20130317205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'Conformationally Specific Viral Immunogens' [patent_app_type] => utility [patent_app_number] => 13/890465 [patent_app_country] => US [patent_app_date] => 2013-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23030 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13890465 [rel_patent_id] =>[rel_patent_doc_number] =>)